BROMFENAC OPHTHALMIC SOLUTION
Generic: BROMFENAC SODIUM
Bausch & Lomb Americas Inc.Manufacturer
OPHTHALMICRoute
BROMFENAC SODIUMActive Substance
2013-04-05Original Approval
BROMFENAC OPHTHALMIC SOLUTION is FDA application NDA203168, sponsored by BAUSCH AND LOMB. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-05-07
Bromfenac Ophthalmic Solution 0.09%, 1.7 mL bottle, Rx only, Sterile, Manufactured for: Alembic Pharmaceuticals, Inc., BFailed Impurities/Degradation Specifications
Class II2021-03-15
BROMFENAC OPHTHALMIC SOLUTION 0.09% 1.7ML NDC/UPC 62332-508-17; RX; DROPSCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Top Reported Reactions
1
TREATMENT FAILURE
147 reports
2
DRUG INEFFECTIVE
66 reports
3
EYE PAIN
47 reports
4
PRODUCT DOSE OMISSION ISSUE
35 reports
5
VISUAL IMPAIRMENT
33 reports
6
FATIGUE
31 reports
7
CATARACT
30 reports
8
EYE IRRITATION
30 reports
9
OFF LABEL USE
30 reports
10
ENDOPHTHALMITIS
29 reports